Skip to main content

Table 4 Genes composing the prognostic methylation signature for the 45 stage IIIC CM patients

From: Whole genome methylation profiles as independent markers of survival in stage IIIC melanoma patients

TargetID1 GENE ID2 SYMBOL3 Distance to TSS4 CPG ISLAND5
cg00498305 6571 SLC18A2 480 TRUE
cg01333788 2709 GJB5 93 FALSE
cg02064402 348932 SLC6A18 249 FALSE
cg02415431 3543 IGLL1 760 FALSE
cg03742272 242 ALOX12B 316 FALSE
cg05164634 7480 WNT10B 995 TRUE
cg05492113 7275 TUB 152 FALSE
cg07039113 6280 S100A9 1317 FALSE
cg08929103 1394 CRHR1 1331 FALSE
cg09196959 135644 TRIM40 70 FALSE
cg09395732 6538 SLC6A11 461 TRUE
cg14236389 284756 FLJ33860 58 TRUE
cg14578030 2249 FGF4 1212 FALSE
cg16139316 6280 S100A9 428 FALSE
cg22088368 339669 MGC35206 1049 FALSE
cg24076884 56134 PCDHAC2 569 TRUE
cg26424956 2914 GRM4 83 FALSE
  1. 1 Illumina unique probe identifier;
  2. 2 Unique NCBI's Entrez Gene record (gene identifier) for the gene;
  3. 3 unique gene symbol as established by the HUGO Gene Nomenclature Committee;
  4. 4 distance in base pairs from the putative transcription start site of the gene;
  5. 5 location of the assayed CpG site in a region fulfilling the definition of CpG island.